These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Ethical analysis of withdrawal of pacemaker or implantable cardioverter-defibrillator support at the end of life. Mueller PS; Hook CC; Hayes DL Mayo Clin Proc; 2003 Aug; 78(8):959-63. PubMed ID: 12911044 [TBL] [Abstract][Full Text] [Related]
3. Should implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness be deactivated? Deactivating implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness. An ethical distinction. Kay GN; Bittner GT Circ Arrhythm Electrophysiol; 2009 Jun; 2(3):336-9; discussion 339. PubMed ID: 19808484 [No Abstract] [Full Text] [Related]
4. Perspectives on withdrawing pacemaker and implantable cardioverter-defibrillator therapies at end of life: results of a survey of medical and legal professionals and patients. Kapa S; Mueller PS; Hayes DL; Asirvatham SJ Mayo Clin Proc; 2010 Nov; 85(11):981-90. PubMed ID: 20843982 [TBL] [Abstract][Full Text] [Related]
6. Palliative Care Consultation and Associated End-of-Life Care After Pacemaker or Implantable Cardioverter-Defibrillator Deactivation. Pasalic D; Gazelka HM; Topazian RJ; Buchhalter LC; Ottenberg AL; Webster TL; Swetz KM; Mueller PS Am J Hosp Palliat Care; 2016 Dec; 33(10):966-971. PubMed ID: 26169518 [TBL] [Abstract][Full Text] [Related]
7. Should implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness be deactivated? Deactivating permanent pacemaker in patients with terminalillness. Patient autonomy is paramount. Zellner RA; Aulisio MP; Lewis WR Circ Arrhythm Electrophysiol; 2009 Jun; 2(3):340-4; discussion 340. PubMed ID: 19808485 [No Abstract] [Full Text] [Related]
8. Considerations in Patients With Cardiac Implantable Electronic Devices at End of Life. Gura MT AACN Adv Crit Care; 2015; 26(4):356-63. PubMed ID: 26484996 [TBL] [Abstract][Full Text] [Related]
9. Medicolegal issues arising when pacemaker and implantable cardioverter defibrillator devices are deactivated in terminally ill patients. McGeary A; Eldergill A Med Sci Law; 2010 Jan; 50(1):40-4. PubMed ID: 20349694 [TBL] [Abstract][Full Text] [Related]
10. Cardiac Implantable Electronic Devices and End-of-Life Care: An Australian Perspective. Alhammad NJ; O'Donnell M; O'Donnell D; Mariani JA; Gould PA; McGavigan AD Heart Lung Circ; 2016 Aug; 25(8):814-9. PubMed ID: 27320854 [TBL] [Abstract][Full Text] [Related]
11. Original research: deactivation of ICDs at the end of life: a systematic review of clinical practices and provider and patient attitudes. Russo JE Am J Nurs; 2011 Oct; 111(10):26-35. PubMed ID: 21926561 [TBL] [Abstract][Full Text] [Related]
13. A literature review comparing the experiences and emergent needs of adult patients with permanent pacemakers (PPMs) and implantable cardioverter defibrillators (ICDs). Tagney J J Clin Nurs; 2010 Aug; 19(15-16):2081-9. PubMed ID: 20477907 [TBL] [Abstract][Full Text] [Related]
14. Current use of implantable electrical devices in Sweden: data from the Swedish pacemaker and implantable cardioverter-defibrillator registry. Gadler F; Valzania C; Linde C Europace; 2015 Jan; 17(1):69-77. PubMed ID: 25336667 [TBL] [Abstract][Full Text] [Related]
15. Pacemakers and implantable cardioverter defibrillators--general and anesthetic considerations. Rapsang AG; Bhattacharyya P Braz J Anesthesiol; 2014; 64(3):205-14. PubMed ID: 24907883 [TBL] [Abstract][Full Text] [Related]
16. Quality of life and end-of-life issues for older patients with implanted cardiac rhythm devices. Lampert R Clin Geriatr Med; 2012 Nov; 28(4):693-702. PubMed ID: 23101578 [TBL] [Abstract][Full Text] [Related]
17. Interactions between transvenous nonthoracotomy cardioverter defibrillator systems and permanent transvenous endocardial pacemakers. Geiger MJ; O'Neill P; Sharma A; Skadsen A; Zimerman L; Greenfield RA; Newby KH; Wharton JM; Kent V; Natale A Pacing Clin Electrophysiol; 1997 Mar; 20(3 Pt 1):624-30. PubMed ID: 9080488 [TBL] [Abstract][Full Text] [Related]
18. Treating or Killing? The Divergent Moral Implications of Cardiac Device Deactivation. Pilkington BC J Med Philos; 2020 Jan; 45(1):28-41. PubMed ID: 31889187 [TBL] [Abstract][Full Text] [Related]
19. Octo- and nonagenarians' outlook on life and death when living with an implantable cardioverter defibrillator: a cross-sectional study. Thylén I; Moser DK; Strömberg A BMC Geriatr; 2018 Oct; 18(1):250. PubMed ID: 30342484 [TBL] [Abstract][Full Text] [Related]
20. An up-to-date review of cardiac pacemakers and implantable cardioverter defibrillators. Kuang RJ; Pirakalathanan J; Lau T; Koh D; Kotschet E; Ko B; Lau KK J Med Imaging Radiat Oncol; 2021 Dec; 65(7):896-903. PubMed ID: 34472707 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]